CVE-2018-17538

Public Exploit

Description

Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding of any type of vulnerability

9.8

CVSS

Severity: Critical

CVSS 3.0 •

CVSS 2.0 •

EPSS 0.53%

Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory githubusercontent.com

Affected: n/a n/a

References

Link	Tags
https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Sync_Report.pdf	third party advisory exploit
https://raw.githubusercontent.com/GitHubAssessments/CVE_Assessment_05_2018/master/Evidence_Sync_Report.pdf	third party advisory exploit
https://github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Review_Report.pdf	third party advisory exploit

Frequently Asked Questions

What is the severity of CVE-2018-17538?: CVE-2018-17538 has been scored as a critical severity vulnerability.
How to fix CVE-2018-17538?: To fix CVE-2018-17538, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-17538 being actively exploited in the wild?: It is possible that CVE-2018-17538 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.